Most Read Articles
2 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Yesterday
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 5 days ago
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).

Balanced diet helps fight off glucose intolerance

07 Oct 2020
Greek food is among one of the most nutritious & well-balanced diets for good health.

Eating more balanced meals—composed of grains, vegetables, and fish or meat—lowers the risk of glucose intolerance in obese men, a recent Japan study has found.

Using a self-administered questionnaire, researchers determined the frequency at which a balanced meal was consumed in 8,573 men and 3,327 women. Glycated haemoglobin (HbA1c) ≥6.0 percent at the 3-year follow-up was used as the main criterion for glucose intolerance. This was tracked along with changes in body weight through annual health examinations.

At baseline, the mean body mass index (BMI) in men and women was 23.1 and 21.5 kg/m2, respectively. Throughout the study duration, participants logged a mean change in bodyweight of 0.78 and 0.84 kg, respectively. Eating balanced meals less frequently correlated with greater body weight gain in men (ptrend=0.004) but not in women.

Glucose intolerance developed in 5.4 percent of men and 3.5 percent of women, while incident diabetes mellitus (HbA1c ≥6.5 percent) was detected in 0.6 percent and 0.2 percent, respectively.

Through logistic regression analysis, researchers showed that among obese men, eating balanced meals only <1 days/week significantly increased the risk of glucose intolerance (odds ratio [OR], 1.73, 95 percent confidence interval [CI], 1.02–2.94), as did keeping to a balanced diet only 1–2 days/week (OR, 1.61, 95 percent CI, 1.07–2.42). These were relative to obese men who ate balanced meals every day (ptrend=0.007).

Notably, this interaction persisted even after adjustment for 3-year changes in bodyweight. The frequency of balanced meals had no such effect on non-obese men and among women.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Yesterday
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 5 days ago
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).